Cargando…
Pathogen-like Nanoassemblies of Covalently Linked TLR Agonists Enhance CD8 and NK Cell-Mediated Antitumor Immunity
[Image: see text] Therapies based on Toll Like Receptor agonists (TLRa) are emerging as a promising modality for cancer immunotherapy to recruit antitumor T-cells in unresponsive immunologically “cold” tumors. Often, combinations of agonists are employed to synergistically enhance efficacy. However,...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical Society
2020
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706081/ https://www.ncbi.nlm.nih.gov/pubmed/33274283 http://dx.doi.org/10.1021/acscentsci.0c01001 |